At 29 weeks gestation, a pregnant woman reports vaginal spotting; what management steps should be taken?

Management of Vaginal Spotting at 29 Weeks Gestation

Immediately arrange for ultrasound evaluation (both transabdominal and transvaginal) and avoid digital pelvic examination until life-threatening placental conditions are excluded. 1

Critical First Steps

Do NOT Perform Digital Pelvic Examination

Avoid digital pelvic examination until placenta previa, low-lying placenta, and vasa previa have been excluded through imaging, as this can precipitate catastrophic hemorrhage in these conditions 1.

Immediate Assessment Required

Obtain vital signs to assess hemodynamic stability and evaluate for signs of maternal compromise 2.

Assess the bleeding characteristics:

• Amount (spotting vs. active bleeding)
• Presence or absence of pain (painless bleeding suggests placenta previa; painful bleeding suggests abruption or preterm labor)
• Associated symptoms (contractions, abdominal pain, rupture of membranes)

Imaging Protocol

Primary Diagnostic Approach

Ultrasound is the mainstay for diagnosis and should include 1:

• Transabdominal ultrasound of the pregnant uterus - initial evaluation
• Transvaginal ultrasound - safe and accurate for placenta previa diagnosis and cervical evaluation
• Doppler velocimetry - to assess fetal well-being and vascular abnormalities

Transvaginal ultrasound is both safe and superior for diagnosing placenta previa despite historical concerns 1.

Life-Threatening Conditions to Rule Out

At 29 weeks, vaginal bleeding can indicate serious pathology with significant maternal and fetal mortality risk 1:

High-Risk Diagnoses

1. Placenta previa (1 in 200 pregnancies) - most common serious cause
2. Placental abruption (1% of pregnancies) - associated with fetal death risk
3. Vasa previa (1 in 2,500-5,000 deliveries) - high fetal mortality if undiagnosed
4. Preterm labor with cervical changes
5. Uterine rupture (rare, but consider if prior cesarean or uterine surgery)

Prognostic Significance

Second-trimester bleeding with abnormal ultrasound findings carries a perinatal mortality rate of 258 per 1,000 compared to 30 per 1,000 in controls 3. The presence of intrauterine clot, membrane separation, or placenta previa significantly worsens outcomes 3.

Management Algorithm

If Ultrasound Shows Abnormalities:

• Hospitalization may be required depending on severity 1
• Continuous fetal monitoring
• Consider corticosteroids for fetal lung maturity (appropriate at 29 weeks)
• Prepare for potential preterm delivery
• Serial ultrasounds to monitor progression

If Ultrasound is Normal:

• Close outpatient surveillance
• Patient education on warning signs (increased bleeding, pain, contractions, decreased fetal movement)
• Pelvic rest (no intercourse, nothing per vagina)
• Follow-up within 1-2 weeks or sooner if symptoms worsen

Critical Pitfalls to Avoid

⚠️ Never perform digital examination before imaging - can cause life-threatening hemorrhage with placenta previa 1

⚠️ Do not dismiss "spotting" as benign - even minimal bleeding at this gestational age warrants full evaluation, as approximately half of cases have no identifiable cause but still carry increased risk 1

⚠️ Ultrasound may miss up to 50% of placental abruptions - clinical correlation is essential; if high suspicion persists despite normal ultrasound, manage as abruption 1

⚠️ Second-trimester bleeding increases risk of preterm delivery (RR 1.9), fetal death (RR 6.3), and perinatal death (RR 5.4) even when no cause is identified 3, 4

Disposition

Admit if:

• Active bleeding (more than spotting)
• Hemodynamic instability
• Placenta previa or abruption identified
• Signs of preterm labor
• Fetal compromise on monitoring

Outpatient management acceptable if:

• Minimal spotting only
• Hemodynamically stable
• Normal ultrasound findings
• Reassuring fetal status
• Reliable patient with good follow-up